PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F15VF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $30,690
Award facts
- Contract value 100% obligated
- $30,690.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a $30,690 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, with an ultimate completion date of January 30, 2026. This non-set-aside contract was competitively awarded and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026, which serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications, medical devices, vaccines, and healthcare commodities to military healthcare programs globally.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as Amerisourcebergen), is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs across the Department of Defense and military healthcare systems. The company's contract portfolio demonstrates extensive experience delivering prescription medications, over-the-counter drugs, and specialized medical supplies across multiple therapeutic domains including diabetes treatments, neurological medications, pain management pharmaceuticals, antibiotics, and vaccines. The DLA Medical Supply Chain is planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning capable contractors like Amerisourcebergen to continue serving federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2D826F15VF?
SPE2D826F15VF was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 29, 2026.
How much is contract SPE2D826F15VF worth?
The government has obligated $30,690 on SPE2D826F15VF.
Is contract SPE2D826F15VF an order under another contract?
Yes. SPE2D826F15VF is a delivery order under SPE2DX22D0029, an indefinite delivery contract.
Was contract SPE2D826F15VF competed?
The extent of competition for SPE2D826F15VF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award